NAN Shares Nanosonics Limited
BUY ASX · ASXRecurring consumables and installed ultrasound-disinfection systems support attractive healthcare technology economics.
Future value: $3.88 (+24.40%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Consumables-led recurring revenue and hospital penetration support operating recovery.
- ▸Above 50-day MA (+5.76%)
- ▸~24% upside to price target
Is NAN a buy right now?
Trend: NAN is trading above the 50-day average (+5.44%), RSI 41 — neutral momentum, with a 3-month return of -0.96%.
Valuation & quality: Nanosonics Limited trades on a trailing P/E of 51.7, forward P/E 59.6, PEG 46.36, price-to-book 4.26; fundamentals show net margin 8.7%, return on equity 8.3%, revenue growth -3.2% year on year.
Analyst consensus: 7 analysts have a mean 12-month price target of A$3.88 (+24.4% vs the last close; range A$3.20 – A$5.15), consensus rating “none”.
Our screen: BUY (score 3) — Recurring consumables and installed ultrasound-disinfection systems support attractive healthcare technology economics.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +12.90% | -10.10% | -8.90% | +5.40% | -5.70% | -12.10% | +6.50% | +5.40% |
Fundamentals
Analyst price target
Technical signals
About Nanosonics Limited
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific.
Sector: Healthcare · Industry: Medical Instruments & Supplies · Australia · 508 employees · Website
Related Technology picks
Browse: all ASX stocks · Technology picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.